TrialThe New England journal of medicine2025

Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children.

Sumit Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.